The requirement of genetic diagnostic technologies for environmental surveillance of antimicrobial resistance

Abstract

Antimicrobial resistance (AMR) is threatening modern medicine. While the primary cost of AMR is paid in the healthcare domain, the agricultural and environmental domains are also res-ervoirs of resistant microorganisms and hence perpetual sources of AMR infections in humans. Con-sequently, the World Health Organisation and other international agencies are calling for surveillance of AMR in all three domains to guide intervention and risk reduction strategies. Technologies for detecting AMR that have been developed for healthcare settings are not immediately transfera-ble to environmental and agricultural settings, and limited dialogue between the domains has ham-pered opportunities for cross‐fertilisation to develop modified or new technologies. In this feature, we discuss the limitations of currently available AMR sensing technologies used in the clinic for sensing in other environments, and what is required to overcome these limitations.